RRD 14.86 R.R. Donnelley & Sons Company $RRD added to my

New Post Public Reply Private Reply Replies (0) Message Board
clayton
RRD 14.86 R.R. Donnelley & Sons Company $RRD added to my watch list.

Right now with RRD I am watching the last price 14.86 High 14.87 Low 13.60 Change +1.36 and percent change +10.07%
Do you have any opinions about RRD stock? Share them with me. I would like to know.

RRD R.R. Donnelley & Sons Company
I post everything I am watching. Share your opinions with me. Let me know what you think is HOT or NOT.
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Bamboo Unveils Tailored Home Insurance for Texans

Updated Category News Views 2

Adapt or Get Left Behind: The Texas Insurance Scene In a world where costs are ballooning and the pressure on the wallet grows heavier, here comes Bamboo Insurance swinging into Texas like a hopeful knight. This plucky insurer is rolling out the Texas Essential Homeowner Program, a highly adaptable, admitted policy that promises to put some power back into the hands of...

Continue Reading
JIMMY's Nespure N9: Innovating Coffee and Clean Water

Updated Category News Views 2

Unpacking JIMMY's Latest Innovation at IFA Every now and then, something comes along that makes you think, "Why didn't I think of that?" Well, JIMMY just hit that nail square on the head with its latest concoction—the Nespure N9. Debuting at the IFA 2026 in Berlin, this little gizmo combines water purification with coffee brewing, all from a modestly-sized countertop...

Continue Reading
Dimerix Locks Down A$34M Loan: No Shareholder Dilution

Updated Category News Views 2

Dimerix Grabs Non-Dilutive Funds amid Kidney Trials Here we go with Dimerix's latest move, folks. They roped in A$34 million through a cozy get-together with lenders from Australia and the U.S. What's the kicker? This cash won't touch shareholder equity. So, breathe easy, investors. It's a rare feat to pull off non-dilutive funds these days, especially in the biopharma...

Continue Reading
IVD Study Success: Hybrid Monitoring Boosts Oversight

Updated Category News Views 1

New Strategies for IVD Clinical Studies It's high time we addressed the tangled web of managing in vitro diagnostic (IVD) clinical studies. We're talking about walking a tightrope where sponsors have to juggle regulatory scrutiny, data integrity, and operational efficiency—all while pushing innovation. Simply put, the old ways of doing things just aren't cutting it...

Continue Reading
BMO Sheds U.S. Branches, Eyes Strategic Growth

Updated Category News Views 1

Why BMO is Slimming Down in the States You know, when a heavyweight like BMO Financial Group starts shedding branches left and right, you gotta ask yourself what the grand plan is. In a move that looks more like a strategic dance than an abrupt U-turn, BMO's gotten rid of 138 U.S. branches, handing them over to First-Citizens Bank. We're talking outlets scattered from...

Continue Reading
GreenCore AI Agents Shatter Monthly Record in Ops Surge

Updated Category News Views 2

Dispatch from the Digital Trenches GreenCore Solutions Corp. (GSC) just made a bit of a splash with those numbers any company would salivate over. We're talking 24.5 million AI agent transactions in just one month. If that doesn't jolt your morning coffee, not sure what will. AI Agents Getting Busy For those out of the loop, GSC isn't your run-of-the-mill tech outfit....

Continue Reading
2026 AI Talent Study Reveals Growth and Gaps

Updated Category News Views 2

Pushing Forward Yet Stumbling on the Details We've got a fresh scoop from the AI Leaders Council: They just rolled out their 2026 Corporate AI Talent Study. What's the big fuss? Well, they're tracking how companies are cozying up to artificial intelligence. Let's just say it's a mixed bag this time around. While almost everyone jumped on the AI bandwagon, only a scant 3%...

Continue Reading
CHiQ Secures AI Award, Elevates Smart Home Living

Updated Category News Views 1

CHiQ's Big Win in the AI Game In a world where technology rarely stops spinning, CHiQ has carved its own commendable niche. Snagging the AI Home Ecosystem Brand Award at IFA 2026 in Berlin, the brand's knack for pioneering AI tech isn't just a footnote—it's the whole story. The award—enough to make your competitors green with envy—highlights how far they've come in...

Continue Reading
Crossware Joins Ingram Micro Platform for Wider Reach

Updated Category News Views 4

Email Signature Game Changer Taps New Markets What goes around comes around, they say. Well, in the email signature business, it seems Crossware is putting that old adage to bed by building a highway straight through Ingram Micro's Xvantage platform. Yep, Crossware's shaking hands with Ingram to spread its email signature prowess to even more necks of the woods,...

Continue Reading
Acepodia's ACE723 Clears FDA Hurdle for Hepatocellular Push

Updated Category News Views 5

Unexpected Developments from Acepodia Folks keeping a keen eye on the biotech scene might just raise an eyebrow at Acepodia's latest move. The FDA has given their nod to ACE723, an ambitious dual-payload antibody-drug conjugate (ADC) designed to wrangle with those stubborn cases of unresectable or metastatic hepatocellular carcinoma (HCC). This isn't just another day in...

Continue Reading

Top 5 Most Recently Viewed Articles

Citi Raises Price Target for Blackstone Amid Encouraging Outlook

Updated Category News Views 86

Citi's Updated Outlook on Blackstone Recently, Citi revisited its financial forecast for The Blackstone Group (NYSE: BX), adjusting the price target upward from $157.00 to $170.00 while maintaining a Neutral stance on the stock. This update follows the company's impressive third-quarter performance, which saw Blackstone's stock rise by 6.3% post-earnings announcement....

Continue Reading
Digital Creators Ignite Sales in Premium Video

Updated Category News Views 16

Video Platforms: A New Playground for Digital Creators Alright, folks, let's kick things off with the latest juice on how digital creators are shaking up advertising in the premium video space. We're diving into research cooked up by the Video Advertising Bureau (VAB), and guess what? These creators wield some serious influence. This is not your run-of-the-mill social...

Continue Reading
Top Dividend-Yielding Tech and Telecom Stocks to Watch

Updated Category News Views 209

Investing in High-Dividend Stocks: An Insight In today's fluctuating market, many investors seek stability through dividend-yielding stocks. These stocks typically come from companies with strong cash flows and share their profits with investors via dividends. This approach not only offers potential income but can also be a safeguard during turbulent times. Highlighting...

Continue Reading
PHX Minerals Set to Release Full-Year 2024 Financial Results

Updated Category News Views 171

PHX Minerals Reveals Upcoming Financial Results Announcement PHX MINERALS INC., commonly known as PHX, is preparing to share its financial results for the year that concluded on December 31, 2024. This announcement is eagerly awaited by investors and stakeholders, marking a significant moment in understanding the company’s financial health and future outlook. Details of...

Continue Reading
Exploring Recent Advancements in CARVYKTI and LUCAR-G39D Therapies

Updated Category News Views 333

Significant Clinical Advancements in CARVYKTI® Therapy Legend Biotech Corporation (NASDAQ: LEGN), a prominent player in the field of cell therapy, has recently shared exceptional long-term clinical outcomes for CARVYKTI® (ciltacabtagene autoleucel; cilta-cel) based on the CARTITUDE-1 and CARTITUDE-4 studies. Notably, patients who were triple-class exposed and had...

Continue Reading